Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Inciner8 wins two top accolades for exporting excellence

Southport-based waste management specialist, Inciner8, is celebrating after receiving two top accolades last week, as it was named International Business of the Year by the Echo Regional Business Awards and received a Highly Commended distinction at Insider Media’s Made in the UK Awards national final.

From Inciner8 Limited 1 Apr 2022

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

A Phase 2 clinical trial evaluating various additional COVID-19 booster shots has begun enrolling adult participants in the United States.

31 Mar 2022

Clinical trials for experimental HIV vaccines based on mRNA technology begin in United States

Scientists urge African leaders to demand fair licensing following clinical trials of an HIV vaccine candidate.

30 Mar 2022

FDA requests nearly 34% increase in funding as part of the President’s fiscal year 2023 budget

Today, the U.S. Food and Drug Administration announced it is requesting a total budget of $8.4 billion as part of the President's fiscal year (FY) 2023 budget - a nearly 34% ($2.1 billion) increase over the agency's FY 2022 appropriated funding level for investments in critical public health modernization, core food safety and medical product safety programs and other vital public health infrastructure.

29 Mar 2022

Penn researchers generate functional CAR T cells with enhanced anti-tumor potency in 24 hours

A new approach from Penn Medicine researchers could cut the time it takes to alter patients' immune cells for infusion back into the body to find and attack cancer.

29 Mar 2022

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Researchers applied a previously developed thermostable self-amplifying ribonucleic acid vaccine to COVID-19.

28 Mar 2022

NTU-developed coating for probiotics ensures effective delivery of beneficial bacteria into the intestine

Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed probiotics with a unique edible coating that ensures the beneficial bacteria successfully reach the intestine once they are ingested.

25 Mar 2022

New implantable biotechnology produces and releases CAR-T cells for attacking tumors

Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed an implantable biotechnology that produces and releases CAR-T cells for attacking cancerous tumors.

24 Mar 2022

SEQENS makes multi-million-dollar investment in U.S. R&D laboratory

SEQENS, an integrated leader in the manufacturing of active ingredients and pharmaceutical intermediates, announced a multi-million-dollar investment in its research and development laboratory located in Devens, Mass.

From SEQENS 21 Mar 2022

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

As SARS-CoV-2 has continued to evolve and outsmart existing treatments, scientists have not let up looking for ever-more effective tools to keep people safe and successfully recover from COVID-19, and to prepare for future outbreaks.

18 Mar 2022

Lateral flow assays: The possibilities beyond COVID-19

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences company) about the possibilities lateral flow assays offer in the post-covid healthscape.

From nanoComposix 17 Mar 2022

New way to deliver potential HIV vaccine using mRNA technology

Using mRNA technology like that in the COVID-19 vaccines, researchers have demonstrated a successful way to deliver a potential HIV vaccine, researchers at Duke Human Vaccine Institute report.

15 Mar 2022

Sustainable material-based biosensors for SARS-CoV-2 detection

Researchers conducted a brief review on biosensors based on sustainable materials for SARS-CoV-2 detection.

15 Mar 2022

The Nucleic Acid Experts – Certified Twice!

BioEcho Life Sciences receives two important hallmarks for its quality management – DIN EN ISO 9001:2015 and DIN EN ISO 13485:2016.

From BioEcho Life Sciences GmbH 10 Mar 2022

Biotech spinout receives $42 million to develop 'future-proofed' coronavirus vaccines

Prime Minister Boris Johnson today announced that DIOSynVax, a biotech spinout of the University of Cambridge, will receive $42million to develop a vaccine candidate that could provide protection against both existing and future variants of SARS-CoV-2 - the virus that causes COVID-19 - as well as other major coronaviruses, including those that cause SARS and MERS.

8 Mar 2022

FUJIFILM Healthcare Europe presents ECHELON™ Smart Plus™

ECHELON™ Smart Plus™ with ‘REALISE Plus’ boosts you to the next level, thanks to an impressive enhancement of the SynergyDrive™ Automation Suite.

From FUJIFILM Corporation 8 Mar 2022

Current and future perspectives of mRNA technology

New research reports on the current and future perspectives on messenger ribonucleic acid technology, the platform on which the first successful COVID-19 vaccine was based.

8 Mar 2022

Flow Eighteen38 receives €5 million EUR (c.$5.58 million USD) to expand production and biophysical capabilities

Flow Eighteen38, a protein sciences division created to facilitate and accelerate antibody characterization and protein purification projects, today announced a €5 million EUR (c.$5.58 million USD) investment into its protein production and biophysical characterization capabilities and services from its parent company, FairJourney Biologics S.A. (FJB), leaders in the discovery and optimization of antibodies.

From FairJourney Biologics S.A. 8 Mar 2022

Orbit Discovery and WuXi AppTec sign agreement to access peptide discovery and optimisation technologies

Orbit Discovery is pleased to announce the commencement of a partnership with WuXi AppTec, a leading global provider of R&D and manufacturing services.

8 Mar 2022

UK launches new global partnership to improve girls’ access to education in developing countries

Prime Minister Boris Johnson is launching a new £20 million business partnership as the UK continues to lead global efforts to improve girls' access to education in developing countries.

7 Mar 2022

Manufacturing News and Research

Further Reading

Inciner8 wins two top accolades for exporting excellence

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

Clinical trials for experimental HIV vaccines based on mRNA technology begin in United States

FDA requests nearly 34% increase in funding as part of the President’s fiscal year 2023 budget

Penn researchers generate functional CAR T cells with enhanced anti-tumor potency in 24 hours

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

NTU-developed coating for probiotics ensures effective delivery of beneficial bacteria into the intestine

New implantable biotechnology produces and releases CAR-T cells for attacking tumors

SEQENS makes multi-million-dollar investment in U.S. R&D laboratory

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

Lateral flow assays: The possibilities beyond COVID-19

New way to deliver potential HIV vaccine using mRNA technology

Sustainable material-based biosensors for SARS-CoV-2 detection

The Nucleic Acid Experts – Certified Twice!

Biotech spinout receives $42 million to develop 'future-proofed' coronavirus vaccines

FUJIFILM Healthcare Europe presents ECHELON™ Smart Plus™

Current and future perspectives of mRNA technology

Flow Eighteen38 receives €5 million EUR (c.$5.58 million USD) to expand production and biophysical capabilities

Orbit Discovery and WuXi AppTec sign agreement to access peptide discovery and optimisation technologies

UK launches new global partnership to improve girls’ access to education in developing countries

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®